Company Of The Day: CVS Health
What?
CVS Health (NYSE:CVS) posted a stronger than expected set of Q4 2021 results, with revenue rising 10% year-over-year to $76.6 billion and adjusted EPS coming in at $1.98. However, the company’s outlook for 2022 was mixed, as it reduced the low-end of its operating cash flow guidance range while reiterating its adjusted EPS guidance.
Why?
The company, which operates a drugstore chain and health insurance business, saw higher prescription volumes and higher Covid-19 vaccinations at its stores. The cash flow guidance cut was due to pull forward of some collections in 2021.
So What?
CVS stock declined by almost 5% in Wednesday’s trading.
See Our Complete Analysis For CVS Health
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.
| Returns | Feb 2022 MTD [1] |
2022 YTD [1] |
2017-22 Total [2] |
| CVS Return | -2% | 2% | 33% |
| S&P 500 Return | 2% | -4% | 105% |
| Trefis MS Portfolio Return | 2% | -8% | 264% |
[1] Month-to-date and year-to-date as of 2/10/2022
[2] Cumulative total returns since the end of 2016